Pacer Advisors’s Immunomedics Inc IMMU Stock Holding History

Pacer Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,396	Closed	-$289K	–	1553
2020 Q3	$289K	Buy	+3,396	New	+$172K	0.01%	1131
2018 Q4	–	Sell	-10,967	Closed	-$228K	–	1147
2018 Q3	$228K	Buy	+10,967	New	+$260K	0.01%	1005
2018 Q1	–	Sell	-4,132	Closed	-$67K	–	1163
2017 Q4	$67K	Buy	+4,132	New	+$48.8K	﹤0.01%	991

Pacer Advisors's IMMU Position: Q4 2020 in Review

Pacer Advisors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 3,396 shares — an estimated $289K sold.

Pacer Advisors first reported a position in IMMU in Q4 2017 and held it in 3 quarters. The position peaked at $289K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Pacer Advisors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Pacer Advisors sold 3,396 Immunomedics Inc shares in Q4 2020, an estimated $289K.
Pacer Advisors first reported a position in Immunomedics Inc in Q4 2017 and held it in 3 quarters.
Pacer Advisors's Immunomedics Inc position peaked at $289K in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Pacer Advisors's 13F filing for Q4 2020, filed 20 Jan 2021.